pharmacie et médicaments – Prise en charge des victimes des fluoroquinolones

This written question concerns the compensation for victims of fluoroquinolone antibiotics. It seeks to understand the current measures and potential future actions regarding the management and support for individuals harmed by these drugs. The question addresses the responsibility of pharmaceutical companies and the state in ensuring patient safety and providing recourse for adverse effects.